Also trades as: VANIW (OTC)
VANI NASDAQ
Vivani Medical, Inc.
1W: -3.3%
1M: -12.8%
3M: -10.8%
YTD: -8.7%
1Y: +0.9%
3Y: -0.8%
5Y: -92.4%
$1.20
+0.04 (+3.45%)
Weekly Expected Move ±10.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$13.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$70.9M
52W Range0.923-1.92
Volume378,628
Avg Volume242,501
Beta2.35
Dividend—
Analyst Ratings
Company Info
CEOAdam Mendelsohn
Employees37
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-11-19
Websitevivani.com
5858 Horton Street
Alameda, CA 94608
US
Alameda, CA 94608
US
818 833 5000
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Latest News
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?
Vivani Medical GAAP EPS of -$0.43 misses by $0.01
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Williams Gregg | P-Purchase | 1,587,301 | $1.26 | 2026-05-15 |
| Williams Gregg | P-Purchase | 1,587,301 | $1.26 | 2026-04-15 |
| Williams Gregg | P-Purchase | 264,551 | $1.26 | 2026-03-15 |
| Williams Gregg | P-Purchase | 1,310,680 | $1.03 | 2026-03-15 |
| Williams Gregg | P-Purchase | 264,551 | $1.26 | 2026-02-15 |